For the Inventor, By the Inventor

Enter assignee name

Memphis, TN, United States of America

Gtx Corporation

Calculating rank

USPTO Granted Patents = 55

% Expired Patents = 29.1

CIPO Patents = 3

EPO Patents = 6

Trademarks = 4

Forward Citations = 947

Loading Chart...

Loading Chart...

51 inventors (with patents filed for the assignee):

James T Dalton (33 out of 102 patents)

Ramesh Narayanan (18 out of 43 patents)

Duane Douglas Miller (18 out of 119 patents)

4. Mitchell S Steiner (12 out of 41 patents)

5. Sunjoo Ahn (10 out of 21 patents)

6. Patrick E Bertagna (9 out of 29 patents)

7. Charles B Duke (9 out of 13 patents)

8. Christopher C Coss (8 out of 12 patents)

9. Thamarai Ponnusamy (7 out of 28 patents)

10. Dong-Jin Hwang (7 out of 23 patents)

11. Yali He (7 out of 32 patents)

12. Seoung-Soo Hong (6 out of 10 patents)

13. Wei Li (6 out of 15 patents)

14. Andrew Hamish Duncan (4 out of 7 patents)

15. Li Wang (4 out of 7 patents)

Core Competencies:

Selective Androgen Receptor Modulators

Cancer Treatment

Tracking Device

Footwear Insole

Estrogen Receptor Ligands

Nuclear Receptor Binding Agents

GPS Technology

Prodrugs

Image Processing

Metabolites

Solid Forms

55 patents: Sort by Forward Citations

1. 11272761 - System and method for embedding a tracking device in a footwear insole (2022-03-15),

2. 10743615 - System and method for embedding a tracking device in a footwear insole (2020-08-18),

3. 10441570 - Selective androgen receptor degrader (SARD) Ligands and methods of use thereof (2019-10-15),

4. 10314807 - Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) (2019-06-11),

5. 10301285 - Compounds for treatment of cancer (2019-05-28),

6. 10292453 - System and method for embedding a tracking device in a footwear insole (2019-05-21),

7. 10258596 - Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) (2019-04-16),

8. 10155728 - Compounds for treatment of cancer (2018-12-18),

9. 10093613 - Selective androgen receptor degrader (SARD) ligands and methods of use thereof (2018-10-09),

10. 10035763 - Selective androgen receptor degrader (SARD) ligands and methods of use thereof (2018-07-31),

11. 10017471 - Selective androgen receptor degrader (SARD) ligands and methods of use thereof (2018-07-10),

12. 9981915 - Compounds for treatment of cancer (2018-05-29),

13. 9969683 - Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS) (2018-05-15),

14. 9910862 - System and method for processing location data (2018-03-06),

15. 9854872 - System and method for embedding a tracking device in a footwear insole (2018-01-02),

Company Overview

Gtx Corporation, based in Memphis, TN, specializes in the development of innovative technologies primarily focused on Selective Androgen Receptor Modulators (SARMs) and their applications in cancer treatment. The company also explores advancements in tracking devices, footwear insoles, and various receptor binding agents, including estrogen receptor ligands. With a commitment to enhancing therapeutic options and integrating GPS technology, Gtx Corporation aims to address significant health challenges and improve quality of life through its diverse technological portfolio.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

55 Patents

#17 in Memphis, TN

#59 in Tennessee

#6,470 in US

#12,953 in the World

Memphis, TN, United States of America

Gtx Corporation

Forward Citations = 947

51 inventors:

James T Dalton (33 out of 102 patents)

Ramesh Narayanan (18 out of 43 patents)

Duane Douglas Miller (18 out of 119 patents)

4. Mitchell S Steiner (12 out of 41 patents)

5. Sunjoo Ahn (10 out of 21 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gtx Corporation. Retrieved from https://idiyas.com/company/gtx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…